Evotec offers to acquire cyprotex
WebOct 28, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a scheme of arrangement regulated by the UK takeover code, with already >50% shares secured irrevocable. The acquisition will add to Evotec's revenues and be accretive to …
Evotec offers to acquire cyprotex
Did you know?
WebOct 26, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a scheme of arrangement regulated by the UK takeover code, with already >50% shares secured irrevocable. The acquisition will add to Evotec’s revenues and be accretive to … WebOct 27, 2016 · German biotech firm Evotec has made an offer to acquire UK-based Cyprotex, a specialist pre-clinical… To continue reading The Pharma Letter please login …
WebOct 27, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a … WebOct 27, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a scheme of arrangement regulated by the UK takeover code, with already >50% shares secured irrevocable. The acquisition will add to Evotec's revenues and be accretive to …
http://www.pharmabiz.com/NewsDetails.aspx?aid=98348&sid=2 WebOct 26, 2016 · - Acquisition would add world-leading high-quality ADME-Tox services and strengthen Evotec's leadership in drug discovery - Evotec will pay approximately £ …
WebOct 26, 2016 · Data & APIs. Events. Marketfy
Web22 rows · Oct 26, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 ... With Evotec, a smart idea can unfold and mature, with the help of our many … The Evotec collection. Evotec’s library contains 450,000 compounds consisting … Evotec offers services and alliances based on its state-of-the-art technology … In this section you can find Evotec's current "Conditions of Purchase" available for … Evotec’s mission is to discover and develop highly effective therapeutics and make … furry playing chessWebAbout us. Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and … furry pill bugWebOct 26, 2016 · - Acquisition would add world-leading high-quality ADME-Tox services and strengthen Evotec's leadership in drug discovery - Evotec will pay approximately £ 55.36 m in... April 9, 2024 furry playing tubaWebOct 27, 2016 · German drug discovery company Evotec announced Wednesday that it agreed to acquire contract research organization Cyprotex for €62 million ($67.7 million). The deal is the latest in a string of recent acquisitions for Evotec. The company bought another CRO, Euprotec Ltd., in May 2014 for $2.3 million upfront. furry playing pianoWebAcquisition would add world-leading high-quality ADME-Tox services and strengthen Evotec's leadership in drug discovery Evotec will pay approximately £ 55.36 m (EUR 62.00 m) in cash for the full share capital of Cyprotex and funding of all existing debt of the AIM-listed company Proposed acquisition, unanimously recommended by the board furry play with toys gameWebOct 26, 2016 · * Evotec AG announces its intent to acquire Cyprotex plc * Offer is intended to be implemented by a scheme of arrangement regulated by uk takeover code, … furry pleaseWebYou have not yet registered? Get your account for free. Register Here furry playing drums